CastaƱares, Ethel Jane .

HRN: 22-25-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 1.5GM (VIAL)
11/25/2025
11/27/2025
IV
1.5gm
Q8hr X 2 Doses
Sp LTCS With BTL
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: